Dr. Das is a seasoned chemist with over a decade of laboratory research experience. He possesses a unique blend of experience in the fields of synthetic organic chemistry, medicinal chemistry and drug discovery. His core expertise includes multi-step organic synthesis, parallel and combinatorial synthesis, homogeneous and asymmetric catalysis, methodology development and synthesis of bio-active small molecules of medicinal importance guided by Structure-Activity Relationship (SAR).Dr. Das' academic journey began in India, earning honors in Chemistry from the University of Calcutta (2013) and a Master's from IIT Madras (2015). He then pursued a Ph.D. (2015-2020) at CSIR-National Chemical Laboratory, focusing on organocatalysis and asymmetric synthesis for creating biologically relevant molecules.Seeking broader research horizons, Dr. Das joined Prof. László Kürti's group at Rice University (USA) in 2020. Here, he pioneered sustainable synthetic platforms for complex molecules with medicinal potential. In 2023, Dr. Das' leadership skills came to the fore at Calibr, Scripps Research, where he led preclinical drug candidate design and synthesis, tackling diverse diseases like SARS-CoV-2 and CNS disorders. A published author and reviewer, Dr. Das' scientific contributions extend beyond the lab. Now at Oklahoma State University's NCWR, he leverages his expertise to develop new treatments for pain and addiction.
Oklahoma State University Center for Health Sciences
Tulsa, Oklahoma, USA
National Center for Wellness and Recovery